share_log

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%), etc.

BridgeBio Pharma | SC 13D/A:超过5%持股股东披露文件(修正)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%)等

美股SEC公告 ·  09/17 18:45
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息